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Abstract
Background: Many authors have reported about the high prevalence rates of self-reported back pain in children.
Nevertheless, little is known about the diagnosis of back disorders - regardless of whether the diagnosis is
associated with back pain or not. Therefore, the aim of this study was to analyse the prevalence rates and costs of
diagnosis of back disorders in childhood and youth.
Methods: We conducted a secondary data analysis of a large, population based German data set (2,300,980
insurants of statutory health insurance funds) which allowed for identification of prevalence rates of diagnoses of
back disorders in children (age group 0-14 years) and youths (age group 15-24 years) using three digit ICD-10
codes for dorsopathies (M40 - M54: kyphosis and lordosis; scoliosis; spinal osteochondrosis; other deforming
dorsopathies; ankylosing spondylitis; other inflammatory spondylopathies; spondylosis; other spondylopathies;
spondylopathies in diseases classified elsewhere; cervical disc disorders; other intervertebral disc disorders; other
dorsopathies, not elsewhere classified; dorsalgia). Direct treatment costs were calculated based on the real incurred
costs for cases with a singular diagnosis of a back disorder. Wherever possible, the results of the random sample
were extrapolated to all insurants of statutory health insurance funds (i. e., about 90% of the German population).
Results: We found prevalence rates for the diagnosis of back disorders to range between 0.01 - 12.5%. “Scoliosis”
(M41) and “dorsalgia” (M54) were the most frequent diagnoses in both age groups. Based on these results, it was
calculated that in 2002 alone, approximately 1.4 million children/youths in Germany were diagnosed with
“dorsalgia” (M54), and that the direct costs for back disorders in childhood and youth accounted for at least
100 million Euros.
Conclusions: Instead of focusing on the individual, and self-reported disorder or disability, this analysis allowed for
the detailed evaluation of medical experts’ opinion on back disorders in childhood and youth and for a more
objective or public health oriented insight in the topic of diagnosis of back pain and other back disorders.
However, due to the methodological limitations by using ICD-10 coding, standardized random validity checks of
population based data sets should be mandatory.
Background
Back pain is a cardinal symptom for various diseases of
the back or spine, that is, for “dorsopathies” or back dis-
o r d e r s .I ti sa l s oa c k n o w l e d g e dt ob eac o m m o nc o n d i -
tion in childhood and youth [1-4], with self-reported
one-year prevalence rates of up to 83% [1], and might -
even at this early age - be associated with difficulties
and restrictions in everyday life [5,6]. Although various
authors report high prevalence rates of pain and espe-
cially back pain in children, adolescents, and youths in
Germany [e. g. [7-9]] with three-month prevalence rates
between 30.2 - 49.0%, all of these reports focus on self-
reported back pain. And while self-reported complaints
of back pain seem to be relatively common in these age
groups, the number of children seeking medical care
because of back pain seems to be rather unclear and
might be influenced by age or regional aspects and
furthermore it might have increased over the years.
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of the then examined U.S. adolescents with back pain
sought medical attention. In 1999, 23% of Belgian school
children (aged nine) with low back pain had sought
medical help from a doctor or a physiotherapist [11],
and in 2005, it was reported that 32% of Tunesian chil-
dren and adolescents required medical help because of
back pain [12]. With regard to German children, Roth-
Isigkeit et al. [8] reported that 53% of German children
with back pain visited a doctor. These immense differ-
ences in self-reported health care utilization when
experiencing back pain led to the conclusion, that
besides the analysis of self-reports on back pain, it
might be worthwhile to consider back pain from a more
population based or public health point of view and
evaluate prevalence rates and costs of diagnosis in chil-
dren, youths and adolescents in existing data sets of
health insurances. As, to our knowledge, little is known
about the prevalence rates of diagnosed back disorders
in general in childhood and/or youth, we extended our
research approach, notwithstanding the possible associa-
tion of these disorders with back pain. Therefore this
article addresses the question of prevalence rates of
diagnosis, as well as direct costs of back disorders in
German children and youths. An extensive, population
based dataset focussing on all persons insured in statu-
tory health insurance funds (approximately 90% of the
German population) was used to answer this question.
Methods
Data set
The analyzed data set originally consisted of all insur-
ants of statutory health insurances in Germany in the
year 2002. About 350 statutory health insurance funds,
the 23 associations for statutory health insurance physi-
cians, the German Federal Insurance Authority, the Fed-
eral Pensions Office for Salaried Employees as well as
the German Institute of Medical Documentation and
Information (DIMDI) contributed to this data set which
comprises about 90% of the German population (i.e.
approximately 72 million persons). Along with other
factors, the data set surveys the insurants’ medical diag-
nosis as three digit ICD-10 codes and costs incurred by
in- and outpatient treatment. For scientific evaluation a
3% probability sample (birthday sample) was drawn out
of the whole cohort and is currently available for scien-
tific evaluations by the Federal Office of Statistics. Every
insured or co-insured person, who was born on the 11
th
of any month and was insured for at least one day in
o n eo ft h es t a t u t o r yh e a l t hi n s u r a n c ef u n d s ,w a s
included in this birthday sample, comprising altogether
2,300,980 persons. The basic data file contains informa-
tion about birth year and gender of the insurants, as
well as the ICD-10 codes of all accounting cases. An
analysis of costs per accounting case with regard to spe-
cific ICD-10 diagnosis was conducted by linking the
basic data file with the data files regarding “outpatient
treatment” and “inpatient treatment & operation” using
the insurant’s pseudonymous insurance number, which
is included in all data files. Further details on the dataset
and its collection methods can be gathered from the
German brochure “Federal Office of Statistics and
Länder Statistical Offices, Research Data Centers, Work-
ing Paper no. 22”[13]. Information about risk factors for
diseases (e. g., psychosocial variables, body mass index,
occupation, sports) was not included in this data set.
The gathering of data and the here presented analysis
are in accordance with the German data protection act
and in accordance with local legislation. All patients are
aware of the possibility of anonymous evaluation of
their insurance data. This research conforms to the Hel-
sinki Declaration. Ethics review board approval was not
obtained for these secondary analyses of an existing
public access dataset.
Back disorders
In this study, we focused on three-digit ICD-codes
(M40-M54) in order to report on back disorders in chil-
dren and youths http://www.who.int/classifications/icd/
en. The different conditions summarized under these
codes are depicted in table 1.
Age groups
The definition of children (0-14 years) and youths (15-
24 years) was chosen in accordance with the definition
of the United Nations General Assembly http://www.un.
org. The a priori created age groups were analyzed.
According to the chosen definition, altogether 15.6% of
t h ec o l l e c t i v eh a v et ob er e f e r r e dt oa sc h i l d r e n ,a n d
12.4% have to be referred to as youths.
Statistical methods and calculation of costs
The above described data set was used for a secondary
data analysis. For the evaluation, SAS®-programs were
written and sent to the Federal Office of Statistics,
where the actual analysis was carried out in two steps.
First, the number of the insured children and youths
with a relevant diagnosis, as well as the prevalence rates
of dorsopathies in the 3% birthday sample (three-digit
ICD-10 code, ICD-10 SGB V1.3 (2000-2003)) were cal-
culated. All persons with a relevant diagnosis/ICD-code
(singular diagnosis and/or multiple diagnoses) were
included in the calculation of prevalence rates. These
results were then used to extrapolate the number of
affected children and youths insured with statutory
health insurers in 2002, multiplying them by 33.3. Sec-
ond, the treatment costs, which were based on fee items
according to the German EBM of the year 2002 (EBM:
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gen, common valuation standard for medical treatment),
were calculated in two steps. In the first step, we only
regarded cases (inpatient and/or outpatient cases) where
the relevant musculoskeletal diagnosis was found to be
the only diagnosis (singular diagnosis), leaving out cases
where the relevant disease was coded as one of more
diagnoses, as the existence of other diagnoses (other
musculoskeletal diagnosis or other than musculoskeletal
diagnosis) might have influenced the corresponding
costs. As having a singular diagnosis was only true for a
small subgroup of affected children and youths, gaps in
the table occurred, where the mean costs, in accordance
with the relevant data protection act, were not calcu-
lated because of too small case numbers (<5). The real
incurred costs for back disorders in children and youths
in the 3% birthday sample were then added up. In the
second step, we tried to estimate (minimum estimation)
the costs incurred by back disorders in children and
youths in all statutory insurants in 2002. Here, we only
regarded costs of outpatient treatment and multiplied
the average costs of the respective singular diagnosis by
the extrapolated prevalent case numbers and finally
summed up the calculated costs. Assuming that all pre-
valent cases created at least the average costs of one
outpatient treatment, these calculations are to be
regarded as a minimum estimation of the costs which
are caused by dorsopathies in childhood and youth.
Results
Prevalence rates of diagnosis of back disorders in
German children and youths
Altogether, 644,773 children and youths (female: 49.3%;
male: 50.7%) were included in this evaluation. Of those,
359,922 (female: 48.9%; male: 51.1%) were between 0-14
years old and 284,851 (female: 49.7%; male: 50.3%)
between 15-24 years old. Table 2 depicts the exact case
number in the 3% birthday sample, the extrapolated
number of all concerned children and youths of the
statutory insurants as well as the respective prevalence
rates (gender- and age-stratification) according to the
different ICD-10 codes. It became obvious that a) the
prevalence rates of diagnosis of dorsopathies range
between 0.01% - 14.1%, b) many diagnosis seem to be
age-dependent, especially with regard to M53 “other
dorsopathies, not elsewhere classified” and M54 “dorsal-
gia”, as well as c) that there were only rather small gen-
der differences found in these two age-groups. In
summary it can be said that M41 (“scoliosis”, prevalence
of diagnosis: 2.31%), M54 (“dorsalgia”,p r e v a l e n c eo f
diagnosis: 1.68%), and M43 (“other deforming dorsopa-
thies”, prevalence of diagnosis: 1.33%) were found to be
the main diagnoses for children (0-14 years), while M54
(“dorsalgia”, prevalence of diagnosis: 12.67%), M53
(“other dorsopathies”, not elsewhere classified, preva-
lence of diagnosis: 3.95%) and M41 (“scoliosis”,p r e v a -
lence of diagnosis: 3.44%) were the main diagnoses for
youths (15-24 years). When extrapolating the prevalence
rates to all insurants, it becomes clear that a large num-
ber of children and youths was diagnosed with back dis-
orders and that in the year 2002 alone, about 1.4 million
German children/youths were diagnosed with back pain
(M54).
Treatment costs for back disorders in German children
and youths
Table 3 shows the mean costs for in- and outpatient
treatment due to singular diagnoses of back disorders.
In the 3% random sample and the age group between 0-
14 years, a total of 200,000 € were spent on outpatient
treatment and about 209,000 € on inpatient treatment
(disorders included in this cost analysis were: M41: “sco-
liosis”, M43: “other deforming dorsopathies, M51: “other
intervertebral disc disorders”,a n dM 5 4 :“dorsalgia”). In
the 3% random sample and the age group between 15-
24 years about 731,000 € were spent on outpatient
Table 1 back disorders according to ICD-10 (2002 version)
M40-43: deforming dorsopathies M40: kyphosis and lordosis
M41: scoliosis
M42: spinal osteochondrosis
M43: other deforming dorsopathies
M45-M49: spondylopathies M45: ankylosing spondylitis
M46: other inflammatory spondylopathies
M47: spondylosis
M48: other spondylopathies
M49: spondylopathies in diseases classified elsewhere
M50-M54: other dorsopathies M50: cervical disc disorders
M51: other intervertebral disc disorders
M53: other dorsopathies, not elsewhere classified
M54: dorsalgia
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§ and prevalence rates of dorsopathies (ICD-10) in German children and youths
age group (0-14 years)* age group (15-24 years)** total collective
#
ICD10 number of
cases
extra-
polation
prevalence
(%)
number of
cases
extra-
polation
prevalence
(%)
number of
cases
extra-
polation
prevalence
(%)
M40 kyphosis and lordosis
F 1,857 61,838 1.05 1,807 60,173 1.28 3,664 122,011 1.15
M 1,689 56,244 0.92 1,836 61,139 1.28 3,525 117,383 1.08
Σ 3,546 118,082 0.99 3,643 121,312 1.28 7,189 239,394 1.11
M41 scoliosis
F 4,428 147,452 2.51 5,387 179,387 3.80 9,815 326,840 3.09
M 3,899 129,837 2.12 4,402 146,587 3.07 8,301 276,423 2.54
Σ 8,327 277,289 2.31 9,789 325,974 3.44 18,116 603,263 2.81
M42 spinal osteochondrosis
F 276 9,191 0.16 984 32,767 0.70 1,260 41,958 0.40
M 319 10,623 0.17 1,525 50,783 1.07 1,844 61,405 0.56
Σ 595 19,814 0.17 2,509 83,550 0.88 3,104 103,363 0.48
M43 other deforming dorsopathies
F 2,292 76,324 1.30 2,109 70,230 1.49 4,401 146,553 1.38
M 2,490 82,917 1.35 1,844 61,405 1.29 4,334 144,322 1.33
Σ 4,782 159,241 1.33 3,953 131,635 1.39 8,735 290,876 1.35
M45 ankylosing spondylitis
F 10 333 0.01 84 2,797 0.06 94 3,130 0.03
M 23 766 0.01 122 4,063 0.09 145 4,829 0.04
Σ 33 1,099 0.01 206 6,860 0.07 239 7,959 0.04
M46 other inflammatory spondylopathies
F 23 766 0.01 121 4,029 0.09 144 4,795 0.05
M 12 400 0.01 91 3,030 0.06 103 3,430 0.03
Σ 35 1,166 0.01 212 7,060 0.07 247 8,225 0.04
M47 spondylosis
F 205 6,827 0.12 1,491 49,650 1.05 1,696 56,477 0.53
M 137 4,562 0.08 977 32,534 0.68 1,114 37,096 0.34
Σ 342 11,389 0.01 2,468 82,184 0.87 2,810 93,573 0.44
M48 other spondylopathies
F 43 1,432 0.02 135 4,496 0.10 178 5,927 0.06
M 37 1,232 0.02 128 4,262 0.09 165 5,495 0.05
Σ 80 2,664 0.02 263 8,766 0.09 343 11,422 0.05
M49 spondylopathies in diseases classified elsewhere
F 15 500 0.01 11 366 0.01 26 866 0.01
M 19 633 0.01 12 400 0.01 31 1,032 0.01
Σ 34 1,132 0.01 23 766 0.01 57 1,898 0.01
M50 cervical disc disorders
F 129 4,296 0.07 527 17,549 0.37 656 21,845 0.21
M 96 3,197 0.05 256 8,525 0.18 352 11,722 0.11
Σ 222 7,393 0.06 783 26,074 0.27 1,008 33,566 0.16
M51 other intervertebral disc disorders
F 116 3,863 0.07 1,294 43,090 0.91 1,410 46,953 0.44
M 102 3,397 0.06 1,174 39,094 0.82 1,276 42,491 0.39
Σ 218 7,259 0.06 2,468 82,184 0.87 2,686 89,444 0.42
M53 other dorsopathies, not elsewhere classified
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This age-dependent increase in costs is mainly due to
t h ei n c r e a s ei nc a s en u m b e r sa n dn o tt oa ni n c r e a s ei n
costs per case. The total costs for these two age groups
add up to approximately €1.9 million being spent on
direct treatment for back disorders (only singular diag-
nosis) in the 3% birthday cohort in Germany in 2002.
Now, in order to make a minimum estimation of the
costs incurred by all children and youths insured with
statutory health insurers, we extrapolated the costs
assuming that all prevalent cases received outpatient
treatment at least once. Here, the overall costs would
add up to approximately 100 million € for the year
2002. As several diagnoses could not be analyzed due to
too small case numbers, this estimation does not depict
the whole truth.
Discussion
In the scientific literature, there seems to be large differ-
ences in health care utilization of children and youths
with back pain [8,10-12]. In particular, German children
with back pain were reported to seek out medical care
more often (in 53% of the cases) than children and ado-
lescents elsewhere (7-32%). Apart from back disorders
which are associated with the clinical feature back pain
there are other back disorders, not necessarily associated
with back pain, of which we know only little with regard
to prevalence rates in children and youths. This situa-
tion gave us reason to believe, that it might be necessary
to reappraise the number of diagnosis of back disorders
for German children and the accordingly incurred costs
from a public health point of view.
In the 3% random sample of all Germans insured with
statutory health insurers, which was available for scienti-
fic analysis, we found that altogether 7.4% of the insured
children between 0-14 years and 25.9% of the insured
youths between 15-24 years were diagnosed with a back
disorder. Assuming that all of those patients experienced
back pain, and considering the reported health care uti-
lization of 53% [8], we could estimate a one year preva-
lence rate of back pain of about 15% in children and a
one year prevalence rate of about 52% in youths. These
prevalence rates seem to be very high and of course it
has to be taken into account that not all back disorders
are associated with back pain, e. g. scoliosis (M41). As
other authors (e. g. [9]) reported a three month preva-
lence rate for back pain of 38.6% (in German children
and adolescents aged 10 - 18 years), and one year preva-
lence rates for lower back pain between 7-63% in ado-
lescents [1], our results at least seem to cover a large
proportion of children and youths seeking out a doctor
because of back pain.
In 2007, Kamtsiuris et al. [14] questioned German
children and adolescents (and their parents) and
reported that scoliosis was diagnosed in 5.2% of all
examined 0-17 years olds in Germany. Girls were more
often affected (6.0%) than boys (4.4%), whereby the gen-
der difference was especially pronounced in the age
groups between 11-13 years and 14-17 years. The
authors themselves discuss that the reliability of the
diagnosis, reported by the “patients” themselves, is to be
interpreted with caution, as it cannot be differed
between a suspected case and a manifest case. In con-
trast to these results, in our study we found slight age
and gender-effects within the ICD-10 diagnosis M41 for
scoliosis. This might be on the one hand due to metho-
dological issues, as we had to use larger age groups
which might have disguised slight age- and/or gender
effects. On the other hand, the prevalence rates of diag-
nosed scoliosis seem to be lower than reported by
Kamtsiuris et al. [14] which might be due to the metho-
dological differences or due to the fact that we report
the one-year prevalence rates, while Kamtsiuris et al.
reported lifetime prevalence [14]. Kim et al. [15] exam-
ined scoliosis in their review in more detail and reported
the prevalence of scoliosis (defined as case of scoliosis
with a scoliosis curve of 10° or more) in the age group
of over 10 year olds to range between 0.5-3.0%. In addi-
tion, they stated that the gender distribution is fairly
even when the scoliosis-curves are small; however, there
is a clear female predominance as the curve magnitude
increases, with some studies quoting a ratio of 1:8 (male
Table 2 case numbers
§ and prevalence rates of dorsopathies (ICD-10) in German children and youths (Continued)
F 1,380 45,954 0.78 6,928 230,702 4.89 8,308 276,690 2.61
M 1,160 38,628 0.63 4,329 144,155 3.02 5,489 182,784 1.68
Σ 2,540 84,582 0.71 11,257 374,858 3.95 13,797 459,440 2.14
M54 dorsalgia
F 3,308 110,156 1.88 19,961 664,701 14.10 23,269 774,858 7.32
M 2,730 90,909 1.49 16,116 536,663 11.30 18,846 627,572 5.76
Σ 6,038 201,065 1.68 36,077 1,201,364 12.67 42,115 1,402,430 6.53
F: female; M: male;
§ exact numbers of the 3% random sample and extrapolated rounded numbers of the insured German general population; * N (age group
0-14 years): 359,922 (female: 176,155, male: 183,767); ** N (age group 15-24 years): 284,851 (female: 141,680, male: 143,171);
# N (total collective, 0-24 years):
644,773 (female: 317,835, male: 326,938); extrapolation to the whole German general population
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and our results are probably due to the problems which
occur when using ICD-10 codes as indicator of disease,
which does not allow for differentiation between scolio-
sis with smaller angles (<10°) vs. scoliosis with larger
angles (>20°). Another point which should be kept in
mind when interpreting our results is that in Germany
there are standardized physical examinations for chil-
dren (which the statutory health insurer pays for) and
scoliosis might be identified and be coded as an inciden-
tal finding during one of these examinations.
Q u i t eal a r g ea m o u n to fs c i e n t i f i cl i t e r a t u r ec o n s i d e r s
back pain in children and adolescents [e. g. [1,2,5,
10,16-19]]. The one year prevalence rates in these other
reports range from 3.5% - 83%, depending on localiza-
tion (low back > neck > thoracic spine), age (older >
younger), and gender (female > male), whereby Dug-
gleby [20] and Olson [10] reported that only 8% and 7%
of the children/youths respectively with back problems
see a doctor. As described above, more recent German
studies report a three month prevalence of back pain
between 30.2 - 49% [7-9] and according visits to the
doctor in 53% of the back pain cases [8]. Though these
numbers are quite impressive, the reports tell us nothing
about the diagnosis the consulted doctors made. With
our analysis we can close this gap of knowledge at least
Table 3 number of accounting cases (n) and mean costs (per accounting case) for outpatient treatment*
outpatient treatment because of a singular diagnosis of a back
disorder
inpatient treatment because of a singular diagnosis of a back
disorder
age group 0-14 years age group 15-24 years age group 0-14 years age group 15-24 years
ICD10 gender n mean costs per case
in € (single diagnosis)
n mean costs per case
in € (single diagnosis)
gender n mean costs per case
in € (single diagnosis)
n mean costs per case
in € (single diagnosis)
M40** F 351 22.62 169 26.04 F ––––
M 271 21.97 260 24.42 M ––––
M41 F 1861 24.75 1552 25.92 F 43 1,916.91 39 5,146.80
M 1155 24.06 1029 25.24 M 16 5,621.80 14 1,639.58
M42** F 55 37.80 162 31.35 F ––––
M 92 29.20 313 31.86 M ––––
M43 F 565 22.80 412 29.14 F 11 546.24 7 4,022.69
M 637 26.15 442 27.28 M 6 1,726.35 19 5,016.23
M45** F –––– F ––––
M –––– M ––––
M46** F –––– F ––––
M –––– M ––––
M47** F 60 36.88 340 34.06 F ––––
M 38 36.42 252 36.74 M ––––
M48** F 6 68.87 20 37.49 F ––––
M 5 32.61 16 57.83 M ––––
M49** F –––– F ––––
M –––– M ––––
M50** F 36 49.68 161 66.58 F ––––
M 26 54.57 63 64.46 M ––––
M51 F 31 82.24 548 90.85 F –– 61 2,185.05
M 34 112.05 558 93.43 M 5 3,547.22 58 2,306.18
M53** F 314 30.49 1643 31.01 F ––5 401.04
M 269 32.56 1075 28.37 M ––5 807.64
M54** F 866 28.04 7024 29.85 F –– 61 924.92
M 782 27.95 6773 27.28 M 6 464.28 42 931.31
* these numbers refer to either the single diagnosis, or to cases with the relevant MSD as main diagnosis but with possibly other co-diagnoses (multiple
diagnoses); ** in case of a cell entry “–”, there were too small case numbers (<5) for analyzing the data without violating the data protection act; therefore mean
outpatient and inpatient treatment costs for a single diagnosis could not be derived for all ICD-10 codes included in this analysis.
ICD-10 codes: M40: kyphosis and lordosis, M41: scoliosis; M42: spinal osteochondrosis; M43: other deforming dorsopathies; M45: ankylosing spondylitis; M46:
other inflammatory spondylopathies; M47: spondylosis; M48: other spondylopathies; M49: spondylopathies in diseases classified elsewhere; M50: cervical disc
disorders; M51: other intervertebral disc disorders; M53: other dorsopathies, not elsewhere classified; M54: dorsalgia
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younger than 15 years were diagnosed with back pain as
compared to 12.7% of youths between 15-24 years. This
noticeable increase of prevalence with age goes along
with findings of other authors who reported an increas-
ing self-reported prevalence of back pain with age in
children and adolescents [e.g. [1]]. The age dependent
increase might at least partially be due to the growth
period in puberty and problems that arise therein. Apart
from the here presented study, other literature on diag-
nosis of back disorders in childhood and youth is scarce.
But keeping in mind the numbers of affected children
and youths in Germany alone, our results uncover a
need for secondary and tertiary prevention strategies for
musculoskeletal disorders, especially back pain, even at
an early age.
Apart from that, we found a small number of cases
with the medical conditions summarized under M42 to
M51 (M42: “spinal osteochondrosis”; M43: “other
deforming dorsopathies”; M45: “ankylosing spondylitis”;
M46: “other inflammatory spondylopathies”; M47:
“spondylosis"; M48: “other spondylopathies”; M49:
“spondylopathies in diseases classified elsewhere”; M50:
“cervical disc disorders”; M51: “other intervertebral disc
disorders”). This result is not surprising as degenerative
diseases are hidden behind these ICD-10 codes and are
not expected in large numbers in childhood and youth.
The fact that we actually found cases with degenerative
disorders, even at an early age, might also be due to
erroneous ICD-10 coding.
To our knowledge this is the first examination that
focuses on the prevalence rates and costs of back disor-
ders in childhood and youth, which were verified by a
doctor’s diagnosis by means of evaluating a huge popu-
lation-based data set. The use of this large data set is
also our study’s biggest strength [21]. Nevertheless,
using the International Classification of Diagnosis (ICD-
10 code) implies some methodological problems. In gen-
eral, the ICD-10 codes exist of up to five-digit codes. As
only three-digit codes were systematically controlled and
used for statistical analysis in this large data set, we
were confined to a relatively general analytical approach,
leaving no room for more detailed analysis of specific
diseases. However, the use of terminal codes might not
have provided more specific information, as many
authors reported the reliability of coding to decrease
with the increasing levels of the code used (e.g. [22]).
Though the coding of medical entities with classifica-
tions is a hot topic in Germany, as the codes are used for
reimbursement, the reliability of diagnosis coding based
on the ICD-10 is still not clear [14]. A study of Stausberg
et al. [22] found kappa-values between different coding
groups on a three-digit ICD-10 level (full set of diagnosis)
to range between 0.34 -0.58 (i.e. fair to moderate
agreement [23]) and therefore the authors concluded, that
the results concerning the reliability of diagnosis coding
with ICD-10 are to be interpreted with caution. They also
s u g g e s t e dt h a tc o d i n gi nd a ily practice might be worse
than found in their study under “standardized” conditions.
Another study reported ICD-coding to be reliable on
chapter level only and found relevant coding uncertainties
at three- and four-digit coding level, too (kappa-values of
approximately 0.4 and 0.2 for three-digit and four-digit
coding, respectively) [24]. Until now, there have been few
validation studies for routine data of German statutory
health insurances [25]. That is why we can only estimate
the true underlying number of children with each ICD 10
diagnosis as well as the true underlying number of chil-
dren with pain or activity limitations. A current study
might at least allow a glimpse at the validity of coded diag-
nosis of the used data set with regard to the coding of
General Practitioners in Berlin [26]. In this study, the
authors reported a correctness of musculoskeletal disorder
coding of 61% (one-digit code “M”)a n dac o r r e c t n e s so f
M54 coding (“dorsalgia”) of 71%. But while the reliability
and validity of ICD-10 coding on a three-digit basis might
still be under scrutiny, it is a fact that - especially with
regard to population based studies in Germany - ICD-10
coding is often the only available information.
The existing data set allowed for evaluation of the
mean expenditures for outpatient treatments. When
looking at the 3% random sample, we found direct treat-
ment costs of approximately € 1.9 million which shows,
that the treatment costs per case are - on average - rather
low. Age-effects were mainly due to increased prevalence
rates and not to increases in mean costs per case. For
extrapolating the costs caused by all insurants of statu-
tory health insurers, we only considered costs accompa-
nied by single diagnosis. Therefore, the relevant
accounting case numbers were considerably smaller and
do not necessarily reflect the cost profile of the “usual”
case. Apart from that, we assumed that every prevalent
case caused only the average direct treatment cost of out-
patient treatment once per year. Inpatient treatments or
outpatient treatments more than once were not included
in this estimation. Therefore this analysis is only a mini-
mum estimation of the incurring costs and gives only a
first insight into the complex structure of medical
accounting cases associated with back disorders. More
extensive analyses are needed to provide more details.
Nevertheless, the present analysis adds to the existing
knowledge by the mere fact that it is based on real costs
and money spent on musculoskeletal diseases in these
age groups and does not rely on estimations only.
Conclusions
Until now, information on diagnosis of back disorders
in children and youths was scarce. In our study, a
Ochsmann et al. BMC Musculoskeletal Disorders 2010, 11:193
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was used to elucidate this situation. Instead of focuss-
ing on self-reported disorder or disability, this
approach allows for the evaluation of medical experts’
opinion and therefore gives a more objective or public
health oriented insight in the topics “back pain” and
“back disorders”. Some of our results supported the
study results of other authors, other results, like the
lacking gender differences in scoliosis, were rather sur-
prising and might be due to methodological problems
which arise from using ICD-10 coding. Apart from
that, the data set allowed for analysis of direct treat-
ment costs, and disclosed that the age-dependent
increasing health care costs, are due to increasing pre-
valence rates and not due to increasing mean costs
because of more problematic cases. Unfortunately, the
structure of the here examined data set, as well as
other available population-based data sets is not yet
cut out for addressing all open questions with regard
to back disorders of children and adolescents. Standar-
dized random validity checks of these population based
data sets should be mandatory in order to use them
for scientific analyses. Furthermore it might be inter-
esting to give researchers possibilities to contribute
new ideas of data linkage. Finally, an overall similar
construction of large population based data sets would
be very useful to conduct comparisons or to link dif-
ferent data sets holding different information. A closer
interaction between researchers and stakeholders
would be desirable, preferably on a European or even
worldwide level. Nevertheless the results presented in
this paper, provide insight into the prevalence rates of
back disorders as well as minimum cost estimations
for these disorders. These results can be used for com-
parison with future analyses in order to detect changes.
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